Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Key Report Update Section
1.5 Objectives
1.5.1 Objective - 1
1.5.2 Objective - 2
1.5.3 Objective - 3
1.6 Report Information & Market Definitions
1.7 Research methodology
1.7.1 Information Procurement
1.7.2 Purchased Database
1.7.3 Gvr's Internal Database
1.7.4 Primary Research
1.7.5 Research Methodology
1.7.5.1 Commodity Flow Analysis (Model 1)
1.8 List of secondary sources
1.9 List of Abbreviations
Chapter 2 Competitive Analysis
2.1 Company Categorization
2.2 Key Company Market Share Analysis, 2025
2.2.1 Oral And Enteral Nutrition Company Market Share Analysis, 2025 (%)
2.2.2 Parenteral Nutrition Company Market Share Analysis, 2025 (%)
2.3 Company Market Position Analysis, at Overall Clinical Nutrition Market Level, 2025
2.2 Company Profiles
2.2.1 Participants’ Overview
2.2.1.1 Abbott (Nutrition)
2.2.1.1.1 Product Benchmarking
2.2.1.1.2 Strategy Mapping
2.2.1.1.3 Financial Performance
2.2.1.1.4 Sales Revenue Share by Online Sales Channel and Retail Sales Channel
2.2.1.2 Pfizer Inc.
2.2.1.2.1 Product Benchmarking
2.2.1.2.2 Strategy Mapping
2.2.1.2.3 Financial Performance
2.2.1.2.4 Sales Revenue Share by Online Sales Channel and Retail Sales Channel
2.2.1.3 Nestlé S.A.
2.2.1.3.1 Product Benchmarking
2.2.1.3.2 Strategy Mapping
2.2.1.3.3 Financial Performance
2.2.1.3.4 Sales Revenue Share by Online Sales Channel and Retail Sales Channel
2.2.1.4 Otsuka Holdings Co., Ltd.
2.2.1.4.1 Product Benchmarking
2.2.1.4.2 Strategy Mapping
2.2.1.4.3 Financial Performance
2.2.1.4.4 Sales Revenue Share by Online Sales Channel and Retail Sales Channel
2.2.1.5 Mead Johnson & Company, LLC (Reckitt Benckiser Group PLC)
2.2.1.5.1 Product Benchmarking
2.2.1.5.2 Strategy Mapping
2.2.1.5.3 Financial Performance
2.2.1.5.4 Sales Revenue Share by Online Sales Channel and Retail Sales Channel
2.2.1.6 Danone S.A. (Nutricia)
2.2.1.6.1 Product Benchmarking
2.2.1.6.2 Strategy Mapping
2.2.1.6.3 Financial Performance
2.2.1.6.4 Sales Revenue Share by Online Sales Channel and Retail Sales Channel
2.2.1.7 Megalabs
2.2.1.7.1 Product Benchmarking
2.2.1.7.2 Strategy Mapping
2.2.1.7.3 Financial Performance
2.2.1.7.4 Sales Revenue Share by Online Sales Channel and Retail Sales Channel
2.2.1.8 Fresenius Kabi AG
2.2.1.8.1 Product Benchmarking
2.2.1.8.2 Strategy Mapping
2.2.1.8.3 Financial Performance
2.2.1.8.4 Sales Revenue Share by Online Sales Channel and Retail Sales Channel
2.2.1.9 Meiji Holdings Co., Ltd.
2.2.1.9.1 Product Benchmarking
2.2.1.9.2 Strategy Mapping
2.2.1.9.3 Financial Performance
2.2.1.9.4 Sales Revenue Share by Online Sales Channel and Retail Sales Channel
2.2.1.10 Baxter International Inc.
2.2.1.10.1 Product Benchmarking
2.2.1.10.2 Strategy Mapping
2.2.1.10.3 Financial Performance
2.2.1.10.4 Sales Revenue Share by Online Sales Channel and Retail Sales Channel
2.2.1.11 Grifols, S.A.
2.2.1.11.1 Product Benchmarking
2.2.1.11.2 Strategy Mapping
2.2.1.11.3 Financial Performance
2.2.1.11.4 Sales Revenue Share by Online Sales Channel and Retail Sales Channel
2.2.1.12 Daisy FSMP (Jiangsu Daisy FSMP Co., Ltd.)
2.2.1.12.1 Product Benchmarking
2.2.1.12.2 Strategy Mapping
2.2.1.12.3 Financial Performance
2.2.1.12.4 Sales Revenue Share by Online Sales Channel and Retail Sales Channel
2.2.1.13 Ausnutria Dairy Corporation Ltd.
2.2.1.13.1 Product Benchmarking
2.2.1.13.2 Strategy Mapping
2.2.1.13.3 Financial Performance
2.2.1.13.4 Sales Revenue Share by Online Sales Channel and Retail Sales Channel
2.2.1.14 Maifu Nutrition Technology
2.2.1.14.1 Product Benchmarking
2.2.1.14.2 Strategy Mapping
2.2.1.14.3 Financial Performance
2.2.1.14.4 Sales Revenue Share by Online Sales Channel and Retail Sales Channel
Chapter 3 Market Dynamics
3.1 Market lineage outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing geriatric population with higher risk of chronic diseases
3.2.1.2 Growing prevalence of chronic diseases
3.2.1.3 Increasing incidence of Cancer
3.2.1.4 Increasing risk of malnutrition
3.2.1.5 Shifting trend toward the consumption of disease-specific formulas
3.2.1.6 Growing demand for neonatal and preterm enteral feeding
3.2.1.7 Rising organizational strategic initiatives to enhance market presence
3.2.1.8 Growing preference for Home-based enteral feeding in post-acute and chronic care settings
3.2.1.9 Rising use of immuno-nutrition formulas to support post-surgical recovery and critical care
3.2.1.10 Technological advancements in nutrient delivery systems and formulation innovation
3.2.1.11 Consumer shift toward personalized and plant-based clinical nutrition solutions
3.2.1.12 Supportive government and healthcare policies for nutrition intervention programs
3.2.2 Market Restraint Analysis
3.2.3 Industry Challenges
3.2.4 Industry Opportunity Overview
3.3 Pricing Analysis of the Medical Foods Market
3.4 Key End Users
3.5 Technology outlook